EUVIMEDEUVIMED entdecken
Crossref

Genetic background of aminoglycoside-modifying enzymes in various genetic lineages of clinical aminoglycosides-resistant E. coli and K. pneumoniae isolates in Tunisia

Sarra Harbaoui, Sana Ferjani, Mohamed Salah Abbassi iD, Julia Guzmán-Puche, Manuel Causse, Cristina Elías-López, Luis Martínez-Martínez, Ilhem Boutiba-Ben Boubaker

Journal of Applied Microbiology · 2024

DOI: 10.1093/jambio/lxae164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2024. Verfasst von Sarra Harbaoui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Laboratory «Antimicrobial resistance» LR99ES09, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis 1006, Tunisia. Hauptthemen laut MEDLINE: Aminoglycosides, Escherichia coli, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Tunisian Ministry of Higher Education and Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study was conducted to evaluate the in vitro activity of clinically relevant aminoglycosides and to determine the prevalence of genes encoding aminoglycoside modifying enzymes (AMEs) and 16S ribosomal RNA (rRNA) methyltransferases among aminoglycoside-resistant E. coli (n = 61) and K. pneumoniae (n = 44) clinical isolates. Associated resistances to beta–lactams and their bla genes as well as the genetic relatedness of isolates were also investigated. Materials and methods A total of 105 aminoglycoside-resistant E. coli (n = 61) and K. pneumoniae (n = 44) isolates recovered between March and May 2017 from 100 patients hospitalized in different wards of Charles Nicolle Hospital of Tunis, Tunisia, were studied. Minimal inhibitory concentrations of aminoglycoside compounds were determined by broth microdilution method. Aminoglycosides resistance encoding genes [aph(3´)-Ia, aph(3′) IIa, aph(3´)-VIa, ant(2″)-Ia, aac(3)-IIa, aac(3)-IVa, aac(6′)-Ib, rmtA, rmtB, rmtC, armA, and npmA] and bla genes were investigated by PCR and sequencing. Genetic relatedness was examined by multilocus sequence typing (MLST) for representative isolates.

Results

High rates of aminoglycoside resistance were found: gentamicin (85.7%), tobramycin (87.6%), kanamycin (78.0%), netilmincin (74.3%), and amikcin (18.0%). Most common AME gene was aac(3)-IIa (42%), followed by aac(6′)-Ib (36.2%) and aph(3′)-VIa (32.4%). The majority of isolates were resistant to beta–lactams and blaCTX-M-15 was the most common ESBL. The blaNDM-1 and blaOXA-48 were also produced by 1 and 23 isolates, respectively. Novel sequence types have been reported among our isolates and high-risk clonal lineages have been detected, such as E. coli ST43 (ST131 in Achtman MLST scheme) and K. pneumoniae (ST11/ST13).

Conclusions

The high prevalence of aminoglycoside resistance rates and the diversity of corresponding genes, with diverse β-lactamase enzymes among genetically heterogeneous clinical isolates present a matter of concern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminoglycosidesEscherichia coliAnti-Bacterial AgentsMicrobial Sensitivity TestsKlebsiella pneumoniaeTunisiaHumansEscherichia coli InfectionsDrug Resistance, BacterialMethyltransferasesKlebsiella Infectionsbeta-LactamasesBacterial Proteins

Stichwörter der Autor:innen

Escherichia coliKlebsiella pneumoniaeaminoglycoside modifying enzymesaminoglycoside resistancehigh-risk clonal lineages

Substanzen

AminoglycosidesAnti-Bacterial AgentsMethyltransferasesbeta-LactamasesBacterial Proteins

Autor:innen und Institutionen

  • Research Laboratory «Antimicrobial resistance» LR99ES09, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis 1006, Tunisia.
  • Laboratory of Microbiology, Charles Nicolle Hospital, Boulevard 9 Avril, Tunis 1006, Tunisia.
  • Laboratory of Bacteriological Research, Institute of Veterinary Research of Tunisia, University of Tunis El Manar, Tunis 1006, Tunisia.
  • Unidad de Gestión Clínica de Microbiologia, Hospital Universitario Reina Sofía de Córdoba, Córdoba 14004, Spain.
  • Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba 14004, Spain.
  • Departamento de Química Agrícola, Edafología y Microbiología, Universidad de Córdoba, Córdoba 14004, Spain.

ORCID-Profile: Mohamed Salah Abbassi

Förderung

  • Tunisian Ministry of Higher Education and Scientific Research

Zitieren

APA

Harbaoui, S., Ferjani, S., Abbassi, M. S., Guzmán-Puche, J., Causse, M., Elías-López, C., Martínez-Martínez, L., & Boubaker, I. B. (2024). Genetic background of aminoglycoside-modifying enzymes in various genetic lineages of clinical aminoglycosides-resistant E. coli and K. pneumoniae isolates in Tunisia. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae164

Vancouver

Harbaoui S, Ferjani S, Abbassi MS, Guzmán-Puche J, Causse M, Elías-López C, et al. Genetic background of aminoglycoside-modifying enzymes in various genetic lineages of clinical aminoglycosides-resistant E. coli and K. pneumoniae isolates in Tunisia. Journal of Applied Microbiology. 2024. doi:10.1093/jambio/lxae164

BibTeX
@article{Harbaoui2024,
  author = {Harbaoui, Sarra and Ferjani, Sana and Abbassi, Mohamed Salah and Guzmán-Puche, Julia and Causse, Manuel and Elías-López, Cristina and Martínez-Martínez, Luis and Boubaker, Ilhem Boutiba-Ben},
  title = {Genetic background of aminoglycoside-modifying enzymes in various genetic lineages of clinical aminoglycosides-resistant E. coli and K. pneumoniae isolates in Tunisia},
  journal = {Journal of Applied Microbiology},
  year = {2024},
  doi = {10.1093/jambio/lxae164}
}
Kostenlos starten →